ARTICLE | Company News
Upsher-Smith, MRC deal
December 8, 2014 8:00 AM UTC
Upsher-Smith’s Proximagen Ltd. U.K. subsidiary and MRC partnered to identify and develop small molecules targeting macrophage migration inhibitory factor (MIF) to treat inflammatory and autoimmune di...